Published in J Diabetes Investig on August 02, 2010
Visfatin and resistin: Mediators of the pleiotropic effects of incretins? J Diabetes Investig (2012) 0.75
Relevance Study on Cerebral Infarction and Resistin Gene Polymorphism in Chinese Han Population. Aging Dis (2016) 0.75
Resistin is an inflammatory marker of atherosclerosis in humans. Circulation (2005) 3.52
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun (2003) 3.16
An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med (2004) 2.51
Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab (2003) 2.39
Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun (2004) 1.92
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet (2004) 1.91
The potential role of resistin in atherogenesis. Atherosclerosis (2005) 1.62
Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab (2006) 1.38
Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia (2004) 1.27
High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes (2004) 1.24
Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab (2008) 1.16
Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis (2006) 1.13
Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta (2006) 1.10
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun (2005) 1.07
Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol (Oxf) (2007) 1.04
Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes (2008) 1.04
Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med (2005) 1.03
Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab (2005) 1.03
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med (2007) 1.03
Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pract (2009) 0.92
Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin. Int J Cardiol (2009) 0.86
Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept (2008) 0.85
Causes of death in Japanese diabetics: A questionnaire survey of 18,385 diabetics over a 10-year period. J Diabetes Investig (2010) 2.40